BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q1 2023 Earnings Call Transcript May 8, 2023
BioXcel Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.84 EPS, expectations were $-1.62.
Operator: Good morning, and welcome to the BioXcel Therapeutics First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Just to remind everyone, certain matters discussed in today’s conference call and or answers...
